Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Haemato AG buy Covacoro

Haemato AG
Start price
€48.68
11.01.16 / 50%
Target price
€60.00
19.12.16
Performance (%)
35.15%
End price
€62.79
19.12.16
Summary
This prediction ended on 19.12.16 with a price of €62.79. With a performance of 35.15% the BUY prediction by Covacoro was a big success. Covacoro has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Haemato AG - - - -
iShares Core DAX® -0,38 % 1,09 % 11,64 % 60,42 %
iShares Nasdaq 100 -0,41 % -1,97 % 7,27 % 87,82 %
iShares Nikkei 225® 1,84 % 10,26 % 31,38 % 66,93 %
iShares S&P 500 -0,71 % 0,44 % 4,30 % 60,46 %

According to Covacoro what are the pros and cons of Haemato AG for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Cons

Comments by Covacoro for this prediction

In the thread Haemato AG diskutieren
Prediction Buy
Perf. (%) 35.15%
Target price 6.000
Change
Ends at 19.12.16

Haemato - profitabel, parallel, pfiffig

- gute Q3-Zahlen und ausgezeichnete Q4-Zahlen

- guter Ausblick auf 2016

- Wachstum voraus

Wer mehr Details lesen will, findet sie hier

http://www.covacoro.de/2016/01/11/haemato-profitabel-parallel-pfiffig/


Covacoro 
0
Report Share
11.01.16
Prediction Buy
Perf. (%) 35.15%
Target price 6.000
Change
Ends at 19.12.16

(Zielkurs erreicht)

Covacoro 
0
Report Share
19.12.16

Stopped prediction by Covacoro for Haemato AG

buy
Haemato AG

Start price
Target price
Perf. (%)
€28.90
02.05.21
€35.00
02.05.22
-4.50%
15.05.21

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Covacoro 
02.05.21 0%